Drugs / Methacholine

Regulatory milestones approvals, filings & regulatory actions · 2 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Label expansion US (FDA) PROVOCHOLINE 2019-11-08 fda.gov
Approved US (FDA) PROVOCHOLINE 1986-10-31 fda.gov

Trials 10 · a red edge is where a trial was stopped

198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 34 trials
Phase 3 NCT03505489 Jun 2018 → Apr 2019 asthma University of Saskatchewan Completed No outcome recorded
Phase 3 NCT02100267 Apr → Sep 2014 asthma Sanwa Kagaku Kenkyusho Co., Ltd. Completed No outcome recorded
Phase 3 NCT02097537 Feb → Jul 2014 asthma Santen Pharmaceutical Co., Ltd. Completed No outcome recorded
Phase 3 NCT00252291 Nov 2005 → Sep 2006 asthma Syntara Completed No outcome recorded
Phase not applicable6 trials
NCT05634473 Dec 2022 → Feb 2023 asthma Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Unknown No outcome recorded
NCT02630511 Dec 2015 → Dec 2020 asthma University of Alberta Completed No outcome recorded
NCT03062904 Feb 2014 → Dec 2019 Assistance Publique - Hôpitaux de Paris Unknown No outcome recorded
NCT01547286 May 2012 → Oct 2013 asthma, atopic IgE-mediated allergic disorder Massachusetts General Hospital Completed No outcome recorded
NCT01064245 Feb 2010 → Dec 2021 cough variant asthma Dr. Diane Lougheed Completed No outcome recorded
NCT00550758 May 2004 → Apr 2007 asthma Rambam Health Care Campus Terminated No outcome recorded
Also used as a comparator or background therapy in 7 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 44 trials
Phase 4 NCT03105843 Background Mar 2022 → Jun 2026 overdue cough variant asthma Dr. Diane Lougheed Recruiting No outcome recorded
Phase 4 NCT02574975 Comparator Apr 2015 → May 2016 asthma Zhujiang Hospital Unknown No outcome recorded
Phase 4 NCT01907334 Comparator Aug 2013 → May 2014 asthma University of Florida Completed No outcome recorded
Phase 4 NCT01642745 Comparator Nov 2011 → Feb 2013 asthma University of Saskatchewan Completed No outcome recorded
Phase not applicable3 trials
NCT01699594 Comparator Oct 2012 → May 2014 allergic asthma University of Saskatchewan Completed No outcome recorded
NCT01919424 Comparator Apr 2011 → Oct 2013 asthma McMaster University Completed No outcome recorded
NCT00145990 Background Sep → Dec 2005 asthma University of Florida Completed No outcome recorded

Evidence & citations 15 cited values

Every value below carries the sentence it was read from. 18 sources stand behind the page.

FieldValueCited text
Known as Methacholine “inhalation of triple-concentration increments (0.06 to13.9mg/ml/methacholine)” NCT00550758
11

NCT03105843

NCT01547286

NCT00145990

NCT02630511

NCT03062904

NCT01919424

NCT02574975

NCT01064245

NCT03505489

NCT00252291

NCT01642745

Known as Chlorure de methacholine ChEMBL registry synonym — accepted as the source's own label CHEMBL978
Known as Cloruro de metacolina ChEMBL registry synonym — accepted as the source's own label CHEMBL978
Known as Mecholyl bromide ChEMBL registry synonym — accepted as the source's own label CHEMBL978
Known as METHACHOLINE BROMIDE ChEMBL registry synonym — accepted as the source's own label CHEMBL978
Known as Methacholine cation ChEMBL registry synonym — accepted as the source's own label CHEMBL978
Known as Methacholine Chloride “Drug: Methacholine ChlorideNCT01919424
5

NCT01699594

NCT02097537

NCT01907334

NCT02100267

NCT05634473

Known as Methacholine ion ChEMBL registry synonym — accepted as the source's own label CHEMBL978
Known as NSC-757090 ChEMBL registry synonym — accepted as the source's own label CHEMBL978
Known as Provocholine “Methacholine (Provocholine)” NCT01642745
Known as SK-1211 “Methacholine Chloride (SK-1211)” NCT02100267
1

“Methacholine Chloride (SK-1211)” NCT02097537

Action Activate “acts as a non-selective muscarinic receptor agonist” NCT01919424
1

“Muscarinic acetylcholine receptor M3 agonist” CHEMBL978

Modality Diagnostic / imaging agent “methacholine challenge test performed in children previously diagnosed with asthma” NCT00550758
Route Inhaled “inhaling methacholine through a nebulizer” NCT00145990
Target CHRM3 “Muscarinic acetylcholine receptor M3 agonist” CHEMBL978